Sophim to double its production capacity thanks to a financial injection

The French company dedicated to the manufacture of natural ingredients has completed a financing round of 20 million euros

27 of September of 2023
Save
Sophim
Sophim

Sophim is looking to become a mid-cap. The French family-owned company that manufactures natural ingredients for the cosmetics industry will inject €20 million into its capital thanks to a financing round that will allow it to double its production capacity in its two plants. 

These €20 million are divided into several items: €4.5 million come from Smart Capital, the only financial investor partner of Sophim since 2014 and that with this move reiterates its confidence in the company. Sophim has also received bank support and financing based on recovery bonds.

"We have found in Smalt Capital a reliable partner who shares our values and supports our ambitions. This investment allows us to double our production capacity on our two industrial sites to meet the strong demand for our products, especially on an international scale," explained Jacques Margna, President of Sophim in a press release. 

This investment responds to the need to accelerate Sophim's growth in order to take a major step in the company's history: from being an SME to a mid-cap.

Even so, Sophim does not want to neglect sustainability, an indispensable pillar of its growth: "In our fast-growing environment, sustainable development must remain a priority. Ecological responsibility is at our heart and has always been an essential element in the development of our business project," says Alexis Margnat, CEO of the French company.